Ionetix plans a $25.8 million expansion at its Lansing facility to add a second cyclotron to produce cancer-fighting ...

After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...

As cancer drug deaths pile up, doctors are increasingly testing for gene variants that can cause thousands of patients to ...

The FDA approved treprostinil (Yutrepia) inhalation powder for pulmonary arterial hypertension and pulmonary hypertension ...

Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...

A more recent prostatectomy was associated with lower likelihood of pGG1 prostatectomy in two cohorts. HealthDay News — Since 2010, there has been a decrease in the proportion of prostatectomies that ...